QT
GBT

Quantamental Technologies’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Quantamental Technologies’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,383
Closed -$204K – 704
2022
Q2 		$204K Buy
+6,383
New +$187K 0.09% 350
2019
Q4 		– Sell
-840
Closed -$41K – 1503
2019
Q3 		$41K Buy
+840
New +$43.8K 0.01% 1030
2019
Q2 		– Sell
-4,878
Closed -$258K – 1914
2019
Q1 		$258K Buy
+4,878
New +$240K 0.12% 289

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Quantamental Technologies's GBT Position: Q3 2022 in Review

Quantamental Technologies sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 6,383 shares — an estimated $204K sold.

Quantamental Technologies first reported a position in GBT in Q1 2019 and held it in 3 quarters. The position peaked at $258K in Q1 2019. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Quantamental Technologies reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
  • Quantamental Technologies sold 6,383 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $204K.
  • Quantamental Technologies first reported a position in Global Blood Therapeutics, Inc. in Q1 2019 and held it in 3 quarters.
  • Quantamental Technologies's Global Blood Therapeutics, Inc. position peaked at $258K in Q1 2019.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Quantamental Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.